search
Back to results

Deep Brain Stimulation for the Treatment of Obesity

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Deep Brain Stimulation Device
Sponsored by
Ali Rezai, MD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Obesity focused on measuring Obesity, DBS

Eligibility Criteria

22 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • At least 24 months post Roux-en-Y gastric bypass surgery without evidence of a sustained improvement in BMI after gastric bypass surgery for at least 6 months.
  • Participant is willing to comply with all follow-up evaluations at the specified times
  • Participant is able to provide informed consent
  • Fluent in English

Exclusion Criteria:

  • Medical contraindications for general anesthesia, craniotomy, or DBS surgery
  • Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or subdural hematomas.
  • Severe cardiovascular, pulmonary, renal, liver, hematological disease, severe coagulopathy, acute infectious process

Sites / Locations

  • The Ohio State University Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

DBS Surgery

Arm Description

All patients enrolled will undergo DBS implantation in the targeted region to assess the safety of the procedure and the efficacy through weight loss.

Outcomes

Primary Outcome Measures

Percentage of excess weight loss
The primary outcome measure at the conclusion of the study will be percent of excess weight loss (EWL).

Secondary Outcome Measures

Full Information

First Posted
January 11, 2012
Last Updated
March 28, 2017
Sponsor
Ali Rezai, MD
search

1. Study Identification

Unique Protocol Identification Number
NCT01512134
Brief Title
Deep Brain Stimulation for the Treatment of Obesity
Official Title
Deep Brain Stimulation For Morbid, Treatment-Refractory, Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
November 2016 (Actual)
Study Completion Date
November 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ali Rezai, MD

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option for obesity.
Detailed Description
The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option in the management of severe, treatment refractory, morbid obesity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Obesity, DBS

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
3 (Actual)

8. Arms, Groups, and Interventions

Arm Title
DBS Surgery
Arm Type
Experimental
Arm Description
All patients enrolled will undergo DBS implantation in the targeted region to assess the safety of the procedure and the efficacy through weight loss.
Intervention Type
Device
Intervention Name(s)
Deep Brain Stimulation Device
Other Intervention Name(s)
Reclaim
Intervention Description
Deep brain stimulation surgery
Primary Outcome Measure Information:
Title
Percentage of excess weight loss
Description
The primary outcome measure at the conclusion of the study will be percent of excess weight loss (EWL).
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: At least 24 months post Roux-en-Y gastric bypass surgery without evidence of a sustained improvement in BMI after gastric bypass surgery for at least 6 months. Participant is willing to comply with all follow-up evaluations at the specified times Participant is able to provide informed consent Fluent in English Exclusion Criteria: Medical contraindications for general anesthesia, craniotomy, or DBS surgery Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or subdural hematomas. Severe cardiovascular, pulmonary, renal, liver, hematological disease, severe coagulopathy, acute infectious process
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ali Rezai, MD
Organizational Affiliation
Ohio State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Ohio State University Medical Center
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32140113
Citation
Weichart ER, Sederberg PB, Sammartino F, Krishna V, Corrigan JD, Rezai AR. Cognitive Task Performance During Titration Predicts Deep Brain Stimulation Treatment Efficacy: Evidence From a Case Study. Front Psychiatry. 2020 Feb 19;11:30. doi: 10.3389/fpsyt.2020.00030. eCollection 2020.
Results Reference
derived

Learn more about this trial

Deep Brain Stimulation for the Treatment of Obesity

We'll reach out to this number within 24 hrs